Quick Answer
ENANTA PHARMACEUTICALS INC reported Total Assets of $280.73 million for fiscal year 2025.
ENANTA PHARMACEUTICALS INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $280.73M | -25.5% |
| 2024 | $376.65M | -18.5% |
| 2023 | $462.27M | +23.1% |
| 2022 | $375.41M | -14.4% |
| 2021 | $438.79M | -9.7% |
| 2020 | $486.13M | -0.8% |
| 2019 | $489.83M | +18.3% |
| 2018 | $414.23M | +26.8% |
| 2017 | $326.64M | +16.1% |
| 2016 | $281.28M | +14.3% |
| 2015 | $246.01M | +58.3% |
| 2014 | $155.41M | +32.9% |
| 2013 | $116.97M | +124.2% |
| 2012 | $52.16M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $329.50M | -5.5% | +17.4% |
| September 30, 2025 | $280.73M | -25.5% | -6.7% |
| June 30, 2025 | $301.03M | -24.5% | -6.8% |
| March 31, 2025 | $322.99M | -21.9% | -7.4% |
| December 31, 2024 | $348.64M | -18.6% | -7.4% |
| September 30, 2024 | $376.65M | -18.5% | -5.6% |
| June 30, 2024 | $398.82M | -19.5% | -3.6% |
| March 31, 2024 | $413.56M | +26.7% | -3.5% |
- ENANTA PHARMACEUTICALS INC showed a decrease of -25.5% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, ENANTA PHARMACEUTICALS INC’s total assets has grown by 438.2% (from $52.16 million to $280.73 million).
- The most recent figure is from ENANTA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 19, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: